Xebio Holdings Co., Ltd.

TSE:8281.T

1142 (JPY) • At close May 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 250,603242,433239,293223,282202,438225,312231,629234,595223,353221,391210,672204,779192,628181,577170,183163,664154,159144,515132,227121,04896,749
Cost of Revenue 158,371149,546147,519136,228123,618136,585143,732141,833134,181135,779129,821123,376117,137109,846104,452101,46294,54689,38082,60677,74761,434
Gross Profit 92,23292,88791,77487,05478,82088,72787,89792,76289,17285,61280,85181,40375,49171,73165,73162,20259,61355,13549,62143,30135,315
Gross Profit Ratio 0.3680.3830.3840.390.3890.3940.3790.3950.3990.3870.3840.3980.3920.3950.3860.380.3870.3820.3750.3580.365
Reseach & Development Expenses 000000000000000000000
General & Administrative Expenses 076,89173,63472,38967,53974,42073,12872,70270,25968,56364,23158,41353,14200000000
Selling & Marketing Expenses 07,4016,3726,1945,0015,6635,3805,1816,3675,6375,4665,3414,93300000000
SG&A 85,22584,29280,00678,58372,54080,08378,50877,88376,62674,20069,69763,75458,07500000000
Other Expenses 04,3917092,3521,4976058705522663946785682882926111,0201,0561,2031,184549192
Operating Expenses 85,22588,68383,44682,05476,05383,47982,13081,84081,74379,44475,19669,10763,44857,47353,64051,25848,83943,88139,45333,06126,980
Operating Income 7,0074,2048,3274,9992,7675,2475,76610,9217,4286,1675,65412,29512,04214,25812,09110,94410,77411,25410,16810,2408,335
Operating Income Ratio 0.0280.0170.0350.0220.0140.0230.0250.0470.0330.0280.0270.060.0630.0790.0710.0670.070.0780.0770.0850.086
Total Other Income Expenses Net -3,9303175091,215328-2,061-1,415-2,063-853-1,470-1,781-319-809110-4,056-662-1,5941,444978679-2,512
Income Before Tax 3,0774,5218,8366,2143,0953,1864,3518,8586,5754,6993,87311,97611,23314,3678,03510,2829,18012,69811,14610,9195,823
Income Before Tax Ratio 0.0120.0190.0370.0280.0150.0140.0190.0380.0290.0210.0180.0580.0580.0790.0470.0630.060.0880.0840.090.06
Income Tax Expense 2,0981,7893,2412,3612,6812,7662,4584,6023,5912,5891,9485,6035,0216,5953,4173,9273,0744,3553,8573,9222,431
Net Income 9712,5925,3973,8364124081,8844,2492,9912,1182,0846,6186,3327,7724,6186,3556,1058,3427,2886,9963,392
Net Income Ratio 0.0040.0110.0230.0170.0020.0020.0080.0180.0130.010.010.0320.0330.0430.0270.0390.040.0580.0550.0580.035
EPS 22.658.63122.0786.779.329.2342.495.0766.8946.9546.24146.91140.68172.68102.6141.23133.46182.11159.13228.18109.69
EPS Diluted 22.4458.32121.5786.449.299.242.3294.7966.7846.8446.17146.67140.54172.57102.57141.23133.46182.04158.9227.98109.68
EBITDA 9,1149,71812,3959,2477,2249,68410,27915,95813,56212,47212,22018,79117,49919,58013,16415,92012,46213,41812,57912,5269,933
EBITDA Ratio 0.0360.040.0520.0410.0360.0430.0440.0680.0610.0560.0580.0920.0910.1080.0770.0970.0810.0930.0950.1030.103